Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observation
Author:
Open Access
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 24 (8) , 1956-1957
Abstract
In a series of transforming initiatives such as the Cancer Genome Atlas, the genomic landscapes for a variety of malignancies have been characterized in a reliable and robust manner and valuable new insights into ‘driver’ mechanisms responsible for the origin and progression of tumors have been gained. As a result of these efforts, we now have precise information on the genomic alterations present in frequent tumors, including breast, colorectal, ovarian, non-small-cell lung cancer, glioblastoma multiforme and endometrial cancer. It is also anticipated that the findings in other tumor types will be reported soon. The type of valuable information that we are acquiring is well exemplified in breast cancer, where just over the last 12 months a series of landmark studies using massively parallel sequencing to hundreds of breast cancers have provided us a comprehensive catalog on somatic mutations [1–6]. We now know that in breast cancer, somatic mutations are frequent in the TP53, PIK3CA and GATA3 genes, among others, and that the four main breast cancer subtypes have different subsets of genetic and epigenetic abnormalities.Keywords
This publication has 13 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Sequence analysis of mutations and translocations across breast cancer subtypesNature, 2012
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- The clonal and mutational evolution spectrum of primary triple-negative breast cancersNature, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerNew England Journal of Medicine, 2012
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel SequencingCancer Discovery, 2012